Reneo Pharmaceuticals says SVB exposure immaterial; accounts hold minimal cash

OnKure Therapeutics, Inc.

• Company maintains operating accounts at Silicon Valley Bank with minimal cash relative to total cash, cash equivalents and investments.
• Believes any loss from SVB receivership is immaterial to its financial position.
• No further details on total cash balance or contingency plans disclosed.